Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 12:00 AM
Ignite Modification Date:
2025-12-25 @ 9:57 PM
NCT ID:
NCT04799158
Pre Assignment Details:
Eligible participants who had symptomatic NERD were initially dosed during an open-label Run-In Period with vonoprazan 20 mg once per day (QD) for 4 weeks. Participants with stable disease (defined by those who had no heartburn on the last 7 consecutive days of the Run-In Period) and were compliant with the electronic diary and study drug were randomized using a 1:1:1:1 allocation ratio to receive either vonoprazan 10 mg, 20 mg, or 40 mg or placebo during the 6-week On-Demand Treatment Period.
Recruitment Details:
This study was performed at 54 sites in the United States between 25 March 2021 and 17 January 2022. Of the 1115 participants screened for the study, 458 participants were enrolled into the Run-In Period. Of these participants, 207 participants were randomized to receive study drug in the On-Demand treatment period.
Study:
NCT04799158
Study Brief:
Results Section:
NCT04799158